FDA Approves Takeda's Orzeyful as Landmark Narcolepsy Treatment
The US Food and Drug Administration has approved Takeda Pharmaceutical's Orzeyful, introducing a novel orexin receptor agonist class for narcolepsy type 1.
Loading lens…
The US Food and Drug Administration has approved Takeda Pharmaceutical's Orzeyful, introducing a novel orexin receptor agonist class for narcolepsy type 1.
Loading lens…